In Silico Design and Evaluation of PRAME+FliCΔD2D3 as a New Breast Cancer Vaccine Candidate
Background: The most prevalent cancer in women over the world is breast cancer. Immunotherapy is a promising method to effectively treat cancer patients. Among various immunotherapy methods, tumor antigens stimulate the immune system to eradicate cancer cells. Preferentially expressed antigen in mel...
Main Authors: | Mortaza Taheri-Anganeh, Amir Savardashtaki, Asma Vafadar, Ahmad Movahedpour, Zahra Shabaninejad, Amir Maleksabet, Ahmad Amiri, Younes Ghasemi, Cambyz Irajie |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2021-01-01
|
Series: | Iranian Journal of Medical Sciences |
Subjects: | |
Online Access: | https://ijms.sums.ac.ir/article_46853_cb1953e06f46127fbc3c7bbc51d3876a.pdf |
Similar Items
-
In silico Evaluation of PLAC1-fliC As a Chimeric Vaccine against Breast Cancer
by: Mortaza Taheri-Anganeh, et al.
Published: (2020-05-01) -
Lack of PRAME Expression in Cutaneous T-Cell Lymphomas
by: Chau M. Bui, et al.
Published: (2021-12-01) -
PRAME gene expression profile in medulloblastoma
by: Tânia Maria Vulcani-Freitas, et al.
Published: (2011-02-01) -
Immunohistochemical analysis of prame expression as a prognostic factor in uveal melanoma patients
by: S. V. Saakyan, et al.
Published: (2021-12-01) -
PRAME Is an Effective Tool for the Diagnosis of Nevus-Associated Cutaneous Melanoma
by: Andrea Ronchi, et al.
Published: (2024-01-01)